[Research and advertisement. Differences in the effectiveness of alendronate according to risk groups]

Aten Primaria. 2001 Apr 30;27(7):528-30. doi: 10.1016/s0212-6567(01)78852-x.
[Article in Spanish]
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Advertising*
  • Alendronate / therapeutic use*
  • Conflict of Interest
  • Drug Industry
  • Female
  • Fractures, Bone / prevention & control*
  • Humans
  • Research
  • Research Support as Topic
  • Risk

Substances

  • Alendronate